Sabra Health Care REIT, Inc. (SBRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.19B |
| Enterprise value | 5.56B |
| Trailing P/E | 229.67 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.95 |
| Price/book (mrq) | 1.14 |
| Enterprise value/revenue | 8.59 |
| Enterprise value/EBITDA | 17.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.17 |
| 52-week change 3 | 26.08% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 14.91 |
| 52-week low 3 | 10.30 |
| 50-day moving average 3 | 14.04 |
| 200-day moving average 3 | 13.68 |
Share statistics
| Avg vol (3-month) 3 | 2.1M |
| Avg vol (10-day) 3 | 1.88M |
| Shares outstanding 5 | 231.48M |
| Implied shares outstanding 6 | 231.48M |
| Float 8 | 228.1M |
| % held by insiders 1 | 1.23% |
| % held by institutions 1 | 94.38% |
| Shares short (28 Mar 2024) 4 | 11.19M |
| Short ratio (28 Mar 2024) 4 | 5.51 |
| Short % of float (28 Mar 2024) 4 | 6.94% |
| Short % of shares outstanding (28 Mar 2024) 4 | 4.83% |
| Shares short (prior month 29 Feb 2024) 4 | 12.75M |
Dividends & splits
| Forward annual dividend rate 4 | 1.2 |
| Forward annual dividend yield 4 | 8.71% |
| Trailing annual dividend rate 3 | 1.20 |
| Trailing annual dividend yield 3 | 8.78% |
| 5-year average dividend yield 4 | 9.06 |
| Payout ratio 4 | 2,000.00% |
| Dividend date 3 | 29 Feb 2024 |
| Ex-dividend date 4 | 12 Feb 2024 |
| Last split factor 2 | 1:3 |
| Last split date 3 | 16 Nov 2010 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 2.13% |
| Operating margin (ttm) | 32.93% |
Management effectiveness
| Return on assets (ttm) | 2.45% |
| Return on equity (ttm) | 0.47% |
Income statement
| Revenue (ttm) | 644.62M |
| Revenue per share (ttm) | 2.79 |
| Quarterly revenue growth (yoy) | 93.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 395.89M |
| Net income avi to common (ttm) | 13.76M |
| Diluted EPS (ttm) | 0.06 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 60.2M |
| Total cash per share (mrq) | 0.26 |
| Total debt (mrq) | 2.43B |
| Total debt/equity (mrq) | 86.59% |
| Current ratio (mrq) | 0.48 |
| Book value per share (mrq) | 12.12 |
Cash flow statement
| Operating cash flow (ttm) | 300.57M |
| Levered free cash flow (ttm) | 245.38M |
© 2024 Yahoo. All rights reserved.